Earnings History Data for Reviva Pharmaceuticals (RVPH) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Reviva Pharmaceuticals
Reviva Pharmaceuticals Inc. is a clinical stage pharmaceutical company. It engages in developing therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company's lead product candidate includes RP5063, for the treatment of schizophrenia, bipolar disorder and major depressive disorder. Reviva Pharmaceuticals Inc., formerly known as Tenzing Acquisition Corp., is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | AH | RVPH | Reviva Pharmaceuticals | 44.00 | -0.25 | -0.23 | 0.00 | Reviva Pharmaceuticals reports Q3 results [11/15/2024 10:25 AM] |
1.12 | -0.08 (-7.02%) |
1.21 | 0.0 (0.00%) |
0.60 - 6.03 | 927,743 | 980,000 | 1,341 | ||
| 14-08-2024 | PM | RVPH | Reviva Pharmaceuticals | 23.00 | -0.26 | -0.28 | 0.00 | 0.7109 | 0.02 (3.10%) |
0.73 | 0.05 (6.60%) |
0.66 - 6.80 | 261,517 | 340,000 | 257 | |||
|
|
||||||||||||||||||
| 14-05-2024 | PM | RVPH | Reviva Pharmaceuticals | 52.00 | -0.25 | -0.28 | 0.00 | Reviva Pharmaceuticals GAAP EPS of -$0.25 [5/14/2024 10:50 AM] |
1.83 | 0.13 (7.65%) |
1.69 | -0.01 (-0.59%) |
1.64 - 8.30 | 467,000 | 350,000 | 7,017 | ||
| 14-08-2023 | AH | RVPH | Reviva Pharmaceuticals | 88.00 | -0.55 | -0.29 | 0.00 | Reviva Pharmaceuticals GAAP EPS of -$0.55 [8/14/2023 5:17 PM] |
4.31 | 0.14 (3.36%) |
0.0 | 0.0 (0.00%) |
0.69 - 9.25 | 74,472 | 130,000 | 0 | ||
| 30-03-2023 | PM | RVPH | Reviva Pharmaceuticals | 86.00 | -0.38 | -0.23 | 0.00 | Reviva Pharmaceuticals GAAP EPS of -$1.25 misses by $0.16 [3/30/2023 7:51 AM] |
4.23 | -0.43 (-9.23%) |
4.52 | -0.14 (-3.00%) |
0.53 - 6.10 | 177,630 | 80,000 | 2,580 | ||
| 14-11-2022 | PM | 4:15 PM ET (Nov 14) |
RVPH | Reviva Pharmaceuticals | 105.00 | -0.18 | -0.30 | 0.00 | Reviva Pharmaceuticals GAAP EPS of -$0.18 [11/15/2022 9:04 AM] |
4.01 | -0.98 (-19.64%) |
4.97 | -0.02 (-0.40%) |
0.53 - 6.10 | 1,110,563 | 660,000 | 3,787 | |
| 15-03-2022 | AH | RVPH | Reviva Pharmaceuticals | 26.00 | -0.24 | -0.24 | 0.00 | Reviva Pharmaceuticals GAAP EPS of -$0.58 beats by $0.05 [3/15/2022 5:19 PM] |
1.82 | 0.10 (5.81%) |
1.72 | 0.0 (0.00%) |
1.53 - 9.50 | 54,687 | 652,363 | 0 | ||
| 15-11-2021 | PM | RVPH | Reviva Pharmaceuticals | 51.00 | -0.12 | -0.25 | 0.00 | Reviva Pharmaceuticals reports Q3 results [11/15/2021 9:01 AM] |
3.60 | -0.18 (-4.76%) |
3.80 | 0.02 (0.53%) |
3.29 - 15.10 | 56,678 | 40,000 | 2,101 | ||
| 16-08-2021 | PM | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 32.00 | -0.12 | -0.24 | 0.00 | Reviva Pharmaceuticals reports Q2 results [8/16/2021 8:47 AM] |
3.36 | -0.14 (-4.00%) |
3.55 | 0.05 (1.43%) |
3.29 - 15.10 | 50,913 | 40,000 | 2,186 | ||